Campbell & CO Investment Adviser LLC Dexcom Inc Transaction History
Campbell & CO Investment Adviser LLC
- $1.3 Billion
- Q3 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Dexcom Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 14,791 shares of DXCM stock, worth $1.2 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
14,791
Previous 10,637
39.05%
Holding current value
$1.2 Million
Previous $1.21 Million
17.83%
% of portfolio
0.08%
Previous 0.11%
Shares
16 transactions
Others Institutions Holding DXCM
# of Institutions
1,015Shares Held
352MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.84 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.79 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.45 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.35 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.22 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...